Market Tracker

03/27 6:45pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

16.82
Delayed Data
As of Mar 27
 +0.26 / +1.57%
Today’s Change
5.40
Today|||52-Week Range
25.60
+4.86%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close16.56
Today’s open16.58
Day’s range16.29 - 17.15
Volume333,543
Average volume (3 months)683,685
Market cap$836.6M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+19.68%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book6.14

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.35-1.58%
TKMRTekmira Pharmaceutic...+0.12+0.69%
RPTPRaptor Pharmaceutica...+0.41+3.55%
ITCIIntra-Cellular Thera...+0.20+0.80%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts